Diagnostic Challenges of Cyclosporiasis in Chronic Diarrhea: A Case Study.

Microorganisms · 2025 · PMC12472525 · PMID 41011540

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Follow-up laboratory tests before the first and second vedolizumab doses showed a decreasing trend in hemoglobin (7.2 g/dL; 6.9 g/dL), while CRP declined (6.1 mg/L; 4.9 mg/L).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.